Shareholders' Equity (Details) |
9 Months Ended |
|---|---|
|
Sep. 30, 2017
$ / shares
shares
| |
| Shareholders' Equity [Abstract] | |
| Warrants outstanding, Exercise price | $ 12.00 |
| Warrants outstanding, Number outstanding at September 30, 2017 | shares | 8,966,667 |
| Warrants outstanding, Weighted average remaining contractual life (years) | 4 months 24 days |
| Warrants outstanding, Weighted average exercise price | $ 12.00 |
| Warrants exercisable, Number exercisable at September 30, 2017 | shares | 8,966,667 |
| Warrants exercisable, Weighted average exercise price | $ 12.00 |
| X | ||||||||||
- Definition Warrants exercisable weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Warrants outstanding range of exercise price. No definition available.
|
| X | ||||||||||
- Definition Warrants outstanding weighted average remaining contractual life. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price of warrants exercisable. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|